ACOG
Alpha Cognition Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Alpha Cognition (ACOG) Stock: Buy, Sell, or Hold?
$8.30
-0.26 (-3.04%)
▼
5d:
+0.12%
30d:
-1.78%
90d:
-6.11%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (82%)
Quality Score
40/100
Position
OVERSOLD
30-Day Fair Range
$8.33 – $8.97
Position: OVERSOLD
Forward P/E & Valuation
-13.4x
Next 12M consensus est.
Wall Street Target
$18.00
+116.9% upside
Options IV & Volume
28th pct IV
HIGH volume confirmation
Support / Resistance
$8.00 / $9.19
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ACOG shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When ACOG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ACOG is currently trading at $8.30, which is considered oversold relative to its 30-day fair value range of $8.33 to $8.97.
Technical Outlook: Technically, ACOG is in a uptrend. Immediate support is located at $8.00, while resistance sits at $9.19. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (28th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $18.00 (+116.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ACOG is in a uptrend. Immediate support is located at $8.00, while resistance sits at $9.19. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (28th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $18.00 (+116.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$8.33 -
$8.97
Company Quality Score
40/100
(SELL)
Options IV Signal
28th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
82.1%
Trading Range & Key Levels
30-Day Trading Range
$8.33 -
$8.97
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.95
(11.5%)
Support Level
$8.00
Resistance Level
$9.19
Current Trend
Uptrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 28th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.0%)
- BULLISH: Trading 116.9% below Wall St target ($18.00)
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-13.39
Wall Street Target
$18.00
(+116.9%)
Revenue Growth (YoY)
267.6%
Profit Margin
-137.7%
Share ACOG Analysis
Share this live ACOG analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ACOG)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
Alpha Cognition (ACOG) reported accelerating commercial momentum for ZUNVEYL in Q3 2026, achieving record levels of net product revenue and prescription volume. Management maintained its target of achieving operating profitability in 2027.
Key Retail Themes:
Revenue expansion
Operating profitability
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:06 PM ET
Data refreshes hourly during market hours. Next update: 6:06 PM
Data refreshes hourly during market hours. Next update: 6:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACOG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 52 HOLD |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 38 SELL |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 43 HOLD |
|
SNDX
Syndax Pharmaceuticals I… |
STRONG BUY
12 analysts |
$35 | 63 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ACOG Research Pages
